Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In
  • Become a Member Org.
  • MB Vision
  • Members
    • Become a Member
    • Benefits
      • Savings and Rewards
    • Member News
    • Member Events
    • Directory
    • Career Center
    • FAQs
    • Pay Company Dues
  • Events
    • Upcoming
    • Types of Events
    • Sponsorship Opportunities
    • The State of Possible Conference
    • Align Summit
    • Member Events
  • Innovation
    • About
    • MassBioDrive
      • Application
      • Alumni
      • Partners
      • Get Involved
      • FAQs
    • CEO & Founder Link
    • Align Summit
    • Partnering
    • Sponsorship Opportunities
  • Savings
    • MassBioEdge
  • Conference Center
    • About MassBioHub
    • Packages & Special Offers
    • Venue Specifications
    • Reserve Today
  • Policy & Advocacy
    • Policy & Advocacy Efforts
    • Diversity, Equity, and Inclusion
      • DEI Report
      • Resource Center
      • Open Letter 2.0
      • Bioversity
    • Economic Development
      • BioReady Communities
    • Workforce Development
      • Bioversity
    • Vision 2030
    • Industry Reports
      • Industry Snapshot
      • Biopharma Funding Report
      • DEI Report
      • MA Life Sciences Workforce
  • About
    • About MassBio
    • MB Vision
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board
    • Career Center
    • Contact Us
  • Sign In
  • Become a Member Org.
  • MB Vision
Open search form

Member News

Click to Open Main Menu
News

Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease

Jan 24, 2021

Posted by Ultragenyx

Download Attachment

See all Member News

Share

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • News & Thought Leadership
  • Pay Company Dues
  • Join Today
  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2024 All Rights Reserved